Enhabit Inc. (NYSE: EHAB) CEO Barb Jacobsmeyer said Wednesday that the company would terminate its contract with the country’s largest Medicare Advantage (MA) payer, UnitedHealth Group’s (NYSE UNH) UnitedHealthcare. UnitedHealthcare accounts for 9.4 million MA beneficiaries, or 29% of all enrollees, according to the Kaiser Family Foundation. Humana Inc. (NYSE: HUM), which is the second-largest […]
Enhabit Inc.
Staying on course with its payer innovation strategy, Enhabit Inc. (NYSE: EHAB) has decided to walk away from certain Medicare Advantage (MA) payers – and namely UnitedHealth Group’s (NYSE: UNH) UnitedHealthcare. That decision, and the recent home health proposed payment rule, were top of mind for Enhabit leaders on Tuesday. Specifically, Enhabit President and CEO […]
Enhabit Inc. (NYSE: EHAB) has announced that its CFO, Crissy Carlisle, will step down from her role. Carlisle has been the chief financial officer of Enhabit since it spun off from Encompass Health Corp. (NYSE: EHC) in 2022. The company has initiated a search to find her replacement. “Crissy has made important contributions to Enhabit […]
To be the beneficiaries of an overwhelming amount of home health demand, providers have to take on a larger share of Medicare Advantage (MA) patients. In the short-term, that doesn’t come off as a financially shrewd strategy, but it makes sense from a long-term perspective. Last week, I wrote about a potential “leveling off” of […]
Following over a year’s worth of public exchanges about the strategic direction of Enhabit Inc. (NYSE: EHAB), the company’s stockholders have voted to elect an activist investor-approved board of directors nominee. During Enhabit’s annual meeting of stockholders on Thursday, the company’s stockholders voted to elect eight of Enhabit’s director nominees, as well as Mark W. […]
Enhabit Inc. (NYSE: EHAB) continues to improve its financial standing and position with Medicare Advantage (MA) partners as it battles with the activist investor AREX Capital Management. The company released an early snapshot of its second-quarter earnings on Monday, ahead of the full, audited release of earnings on Aug. 6. Of Enhabit’s non-Medicare visits, 43% […]
One of home health care’s biggest public battles continued Thursday, as an outside advisory firm made its recommendations regarding the future of the Enhabit Inc. (NYSE: EHAB) board. AREX Capital Management – which owns 4.9% of Enhabit’s outstanding common shares – has been challenging Enhabit’s strategic direction for more than a year. Initially, the activist […]
On Monday, Enhabit Inc. (NYSE: EHAB) defended its strategy of taking on more Medicare Advantage (MA) revenue over the last couple of years. It did so in yet another response to AREX Capital Management, an activist investor that owns 4.9% of Enhabit shares. Enhabit and AREX Capital – which wants to replace Enhabit’s current board […]
The activist investor AREX Capital Management has again taken aim at Enhabit Inc. (NYSE: EHAB) in what has become an ongoing, public and back-and-forth feud. AREX Capital – which owns 4.9% of Enhabit shares, making it a top-5 shareholder – initially urged the Enhabit board to undergo a strategic review last year when the company […]
As the Centers for Medicare & Medicaid Services (CMS) cuts fee-for-service Medicare rates and Medicare Advantage (MA) penetration continues, top-tier home health companies are looking for top-tier payers to work with. Enhabit Inc. (NYSE: EHAB) considers itself a top-tier provider – regularly pointing toward its 30-day hospitalization rate, which was 20.5% below the national average […]